Aug. 23—In today's article, you will be introduced to one of the most common psychiatric conditions, Attention Disorders (AD), or what is now called Attention Deficit Disorder (ADD), or Attention ...
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果